Nanjing Pharmaceutical Group Company LimitedSSE: 600713

Announcement on Outline of the Q3 2025 Performance Briefing

· Issued by Nanjing Pharmaceutical Group Company Limited via Shanghai Stock Exchange

Filed with SSE · · 2 pages · Chinese

Summary by 6ix AI

The briefing was held online, allowing for interaction between company representatives and investors, addressing key questions raised by attendees.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Nanjing Pharmaceutical Group Company Limited on 6ix

Later from Nanjing Pharmaceutical

All Nanjing Pharmaceutical news releases